226 related articles for article (PubMed ID: 26179261)
41. DNA methylation mediated silencing of microRNA-874 is a promising diagnosis and prognostic marker in breast cancer.
Zhang L; Yan DL; Yang F; Wang DD; Chen X; Wu JZ; Tang JH; Xia WJ
Oncotarget; 2017 Jul; 8(28):45496-45505. PubMed ID: 28525377
[TBL] [Abstract][Full Text] [Related]
42. The value of serum RASSF10 hypermethylation as a diagnostic and prognostic tool for gastric cancer.
Xue WJ; Feng Y; Wang F; Li P; Liu YF; Guo YB; Wang ZW; Mao QS
Tumour Biol; 2016 Aug; 37(8):11249-57. PubMed ID: 26945573
[TBL] [Abstract][Full Text] [Related]
43. miR-509-3-5P inhibits the invasion and lymphatic metastasis by targeting PODXL and serves as a novel prognostic indicator for gastric cancer.
Zhang J; Zhu Z; Sheng J; Yu Z; Yao B; Huang K; Zhou L; Qiu Z; Huang C
Oncotarget; 2017 May; 8(21):34867-34883. PubMed ID: 28432273
[TBL] [Abstract][Full Text] [Related]
44. Methylation of the HOXA10 Promoter Directs miR-196b-5p-Dependent Cell Proliferation and Invasion of Gastric Cancer Cells.
Shao L; Chen Z; Peng D; Soutto M; Zhu S; Bates A; Zhang S; El-Rifai W
Mol Cancer Res; 2018 Apr; 16(4):696-706. PubMed ID: 29453320
[TBL] [Abstract][Full Text] [Related]
45. High expression of miR-16 and miR-451 predicating better prognosis in patients with gastric cancer.
Ren C; Chen H; Han C; Fu D; Wang D; Shen M
J Cancer Res Clin Oncol; 2016 Dec; 142(12):2489-2496. PubMed ID: 27605261
[TBL] [Abstract][Full Text] [Related]
46. LINE-1 hypomethylation is not a common event in preneoplastic stages of gastric carcinogenesis.
Kupcinskas J; Steponaitiene R; Langner C; Smailyte G; Skieceviciene J; Kupcinskas L; Malfertheiner P; Link A
Sci Rep; 2017 Jul; 7(1):4828. PubMed ID: 28684753
[TBL] [Abstract][Full Text] [Related]
47. SAMD14 promoter methylation is strongly associated with gene expression and poor prognosis in gastric cancer.
Xu X; Chang X; Xu Y; Deng P; Wang J; Zhang C; Zhu X; Chen S; Dai D
Int J Clin Oncol; 2020 Jun; 25(6):1105-1114. PubMed ID: 32206938
[TBL] [Abstract][Full Text] [Related]
48. Evaluation of circulating miR-21 and miR-222 as diagnostic biomarkers for gastric cancer.
Emami SS; Nekouian R; Akbari A; Faraji A; Abbasi V; Agah S
J Cancer Res Ther; 2019; 15(1):115-119. PubMed ID: 30880765
[TBL] [Abstract][Full Text] [Related]
49. microRNA analysis of gastric cancer patients from Saudi Arabian population.
Bibi F; Naseer MI; Alvi SA; Yasir M; Jiman-Fatani AA; Sawan A; Abuzenadah AM; Al-Qahtani MH; Azhar EI
BMC Genomics; 2016 Oct; 17(Suppl 9):751. PubMed ID: 27766962
[TBL] [Abstract][Full Text] [Related]
50. miR-126: An indicator of poor prognosis and recurrence in histologically lymph node-negative gastric cancer.
Feng R; Sah BK; Li J; Lu S; Yuan F; Jin X; Yan M; Liu B; Li C; Zhu Z
Cancer Biomark; 2018; 23(3):437-445. PubMed ID: 30248047
[TBL] [Abstract][Full Text] [Related]
51. Gastric Juice MicroRNAs as Potential Biomarkers for Screening Gastric Cancer: A Systematic Review.
Virgilio E; Giarnieri E; Giovagnoli MR; Montagnini M; Proietti A; D'Urso R; Mercantini P; Balducci G; Cavallini M
Anticancer Res; 2018 Feb; 38(2):613-616. PubMed ID: 29374683
[TBL] [Abstract][Full Text] [Related]
52. Role of miR-191/425 cluster in tumorigenesis and diagnosis of gastric cancer.
Peng WZ; Ma R; Wang F; Yu J; Liu ZB
Int J Mol Sci; 2014 Mar; 15(3):4031-48. PubMed ID: 24603541
[TBL] [Abstract][Full Text] [Related]
53. Plasma miR-122 and miR-192 as potential novel biomarkers for the early detection of distant metastasis of gastric cancer.
Chen Q; Ge X; Zhang Y; Xia H; Yuan D; Tang Q; Chen L; Pang X; Leng W; Bi F
Oncol Rep; 2014 Apr; 31(4):1863-70. PubMed ID: 24481716
[TBL] [Abstract][Full Text] [Related]
54. Identification of diagnostic utility and molecular mechanisms of circulating miR-551b-5p in gastric cancer.
Jiang X; Jiang M; Xu M; Xu J; Li Y
Pathol Res Pract; 2019 May; 215(5):900-904. PubMed ID: 30732916
[TBL] [Abstract][Full Text] [Related]
55. Methylation-associated silencing of miR-495 inhibit the migration and invasion of human gastric cancer cells by directly targeting PRL-3.
Li Z; Zhang G; Li D; Jie Z; Chen H; Xiong J; Liu Y; Cao Y; Jiang M; Le Z; Tan S
Biochem Biophys Res Commun; 2015 Jan; 456(1):344-50. PubMed ID: 25475733
[TBL] [Abstract][Full Text] [Related]
56. Site-specific Hypermethylation of RUNX3 Predicts Poor Prognosis in Gastric Cancer.
Wang N; Sui F; Ma J; Su X; Liu J; Yao D; Shi B; Hou P; Yang Q
Arch Med Res; 2016 May; 47(4):285-92. PubMed ID: 27664488
[TBL] [Abstract][Full Text] [Related]
57. Long non-coding RNA Fer-1-like protein 4 suppresses oncogenesis and exhibits prognostic value by associating with miR-106a-5p in colon cancer.
Yue B; Sun B; Liu C; Zhao S; Zhang D; Yu F; Yan D
Cancer Sci; 2015 Oct; 106(10):1323-32. PubMed ID: 26224446
[TBL] [Abstract][Full Text] [Related]
58. Diagnostic and Prognostic Value of Serum miR-296-5p and miR-28-3p in Human Gastric Cancer.
Guo Y; Cui X; Zhang Y; Ma X; Ren A; Huang H
Cancer Biother Radiopharm; 2023 Mar; 38(2):95-101. PubMed ID: 32898433
[No Abstract] [Full Text] [Related]
59. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.
Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP
Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144
[TBL] [Abstract][Full Text] [Related]
60. Detection of aberrant hypermethylated spastic paraplegia-20 as a potential biomarker and prognostic factor in gastric cancer.
Zhang H; Song Y; Xia P; Cheng Y; Guo Q; Diao D; Wang W; Wu X; Liu D; Dang C
Med Oncol; 2014 Feb; 31(2):830. PubMed ID: 24381142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
